aXichem’s Polish distributor BART initiates development of a dietary supplement product based on aXivite
aXichem AB (publ), that develops and markets natural analogue industrial compounds, announces that it has received an initial order for aXivite from its Polish distributor Bart Spólka Sp.k. (BART), a producer and supplier of ingredients for dietary supplements, food and beverages in a number of counties in eastern Europe. This first delivery of aXivite will be used as a component in the first steps of the product development process, where the objective is to design a new dietary supplement product.
– I’m very pleased that BART has started this activity on the Polish market. The value in Euro of this first order is limited but the symbolic value is significant. It also confirms the atmosphere at Vitafoods Europe 2021, 5–7 October, in Geneva. We will follow the development of BART’s work closely and are looking forward to the result, says Lucas Altepost, Vice President and VP Sales and Marketing at aXichem.
About aXivite: aXivite (phenylcapsaicin) is a well-studied synthetic capsaicin which is being developed for multiple nutraceutical and pharmaceutical applications. aXivite’s gut-health mechanism of action is particularly associated with reduced inflammation, occurring via a statistically significant reduction in serum zonulin levels. A clinical study has demonstrated a metabolic role for aXivite that induces increased fat-burn leading to healthy weight loss and body shape in healthy subjects. Unpublished and published data with aXivite treatment continue to demonstrate an excellent safety and tolerability profile at both high (1,12 mg/day) and low (0,560mg/day) doses.
About BART: BART is a Polish producer of natural colours, flavours, emulsions and liposomal vitamins. BART offers also colouring foodstuffs, colouring blends and a wide range of ingredients – including botanical extracts - for different food sectors. aXichem signed a distributor’s agreement with BART in November 2020.
This press release was submitted by the contact person below on 20 October 2021, at 09:00 AM CET.
Torsten Helsing, CEO, aXichem, Ph+46 46-780 06 73. Email: firstname.lastname@example.org
Torsten Helsing, CEO aXichem, Ph + 46 46-780 06 73. E-mail: email@example.com
aXichem’s business idea is to develop, patent and market natural analogue industrial compounds. The Company primarily works with phenylcapsaicin a structural analogue of capsaicin with a wide range of applications, such as feed additives, marine anti-fouling products and certain pharmaceutical areas. aXichem’s shares are listed on NASDAQ First North Growth Market under AXIC A. Certified Adviser: Redeye AB Certifiedadviser@redeye.se +46 (0)8 121 576 90. Read more about the company at www.axichem.se